Tower Wealth Partners Inc. Purchases New Shares in CME Group Inc. (NASDAQ:CME)

Tower Wealth Partners Inc. acquired a new stake in CME Group Inc. (NASDAQ:CMEFree Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,638 shares of the financial services provider’s stock, valued at approximately $345,000.

Several other hedge funds also recently bought and sold shares of CME. Naples Global Advisors LLC grew its position in shares of CME Group by 5.6% during the 4th quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock worth $436,000 after buying an additional 110 shares in the last quarter. FNY Investment Advisers LLC bought a new position in shares of CME Group during the 4th quarter worth $1,074,000. Deutsche Bank AG grew its position in shares of CME Group by 4.3% during the 3rd quarter. Deutsche Bank AG now owns 1,118,104 shares of the financial services provider’s stock worth $223,867,000 after buying an additional 46,021 shares in the last quarter. DNB Asset Management AS grew its position in shares of CME Group by 34.6% during the 4th quarter. DNB Asset Management AS now owns 98,317 shares of the financial services provider’s stock worth $20,706,000 after buying an additional 25,257 shares in the last quarter. Finally, Van Hulzen Asset Management LLC grew its position in shares of CME Group by 544.7% during the 3rd quarter. Van Hulzen Asset Management LLC now owns 9,670 shares of the financial services provider’s stock worth $1,936,000 after buying an additional 8,170 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Down 1.5 %

Shares of CME opened at $212.02 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12 month low of $175.73 and a 12 month high of $223.80. The stock’s 50 day moving average is $212.67 and its two-hundred day moving average is $211.01. The firm has a market cap of $76.33 billion, a P/E ratio of 23.90, a PEG ratio of 3.40 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 EPS for the quarter, beating the consensus estimate of $2.27 by $0.10. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period last year, the company earned $1.92 earnings per share. CME Group’s quarterly revenue was up 19.2% compared to the same quarter last year. Analysts predict that CME Group Inc. will post 9.63 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a $1.15 dividend. The ex-dividend date was Thursday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.10. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.17%. CME Group’s payout ratio is currently 51.86%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CME. Barclays upped their price objective on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 15th. Rosenblatt Securities restated a “sell” rating and set a $180.00 price objective on shares of CME Group in a research note on Thursday, January 4th. Argus upped their price objective on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. Finally, The Goldman Sachs Group cut CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective for the company. in a research note on Wednesday, January 3rd. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $217.30.

Read Our Latest Stock Report on CME Group

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.